XML 76 R41.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Federal and State and Foreign Income Tax Provision
The federal and state and foreign income tax provision is summarized as follows: 
Year Ended December 31,202320222021
Current
Federal$133,465 $126,780 $120,939 
State23,621 27,267 24,492 
Foreign8,807 26,255 9,480 
165,893 180,302 154,911 
Deferred
Federal(29,837)(40,619)(7,106)
State(3,620)(4,949)(735)
Foreign(39)(921)10 
(33,496)(46,489)(7,831)
Total income taxes$132,397 $133,813 $147,080 
Schedule of Components of Net Income Before Income Taxes
The components of Income before income taxes are summarized as follows:
Year Ended December 31,202320222021
Domestic$545,642 $474,894 $641,403 
Foreign49,013 134,386 52,270 
$594,655 $609,280 $693,673 
Schedule of Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate
The effective income tax rate differs from the federal income tax statutory rate due to the following:
Year Ended December 31,202320222021
Statutory rate21.0 %21.0 %21.0 %
State taxes, net of federal tax benefit2.6 2.9 2.6 
Foreign tax expense and tax rate differential(0.3)(0.2)(0.1)
Tax benefit from stock option exercises(0.3)(0.7)(1.2)
Research and development tax credit(1.1)(1.1)(1.0)
Foreign-Derived Intangible Income Deduction (FDII)(0.3)(0.3)(0.2)
Other, net0.7 0.4 0.1 
22.3 %22.0 %21.2 %
Schedule of Deferred Tax Assets and Liabilities Significant components of deferred tax assets and liabilities at December 31, 2023 and 2022 are as follows:
20232022
Deferred Tax Assets:
Stock-based compensation expense$35,999 $35,865 
Federal net operating loss and R&D Credit carryforward5,477 6,565 
State net operating loss carryforward 39,820 40,249 
Foreign net operating loss carryforward and other7,486 7,339 
Capitalized research and development11,759 — 
Accrued expense associated with voluntary separation program3,796 9,792 
Basis differences in investments5,111 2,432 
Federal benefit of state tax deduction for uncertain tax positions2,039 1,891 
Revenue and expense recognized in different periods for financial reporting and income tax purposes2,306 2,827 
Other assets
2,509 4,021 
Total deferred income tax assets116,302 110,981 
Less: Federal net operating loss and R&D valuation allowance(794)(794)
Less: State net operating loss valuation allowance(36,966)(36,963)
Less: Foreign net operating loss valuation allowance(7,486)(7,339)
Net deferred income tax assets$71,056 $65,885 
Deferred Tax Liabilities:
Capitalized research and development$ $(24,764)
Difference in financial reporting and income tax depreciation methods(9,679)(12,694)
Difference between book and tax basis of other assets(7,652)(7,265)
Goodwill and other intangibles (6,784)(7,482)
Capitalized contract costs(9,232)(8,744)
Total deferred income tax liabilities$(33,347)$(60,949)
Net deferred income tax assets$37,709 $4,936 
Schedule of Unrecognized Tax Benefits Roll Forward
A reconciliation of the beginning and ending amount of unrecognized tax benefit is as follows:
202320222021
Balance as of January 1$15,204 $14,886 $15,911 
Tax positions related to current year:
Gross additions3,395 3,481 3,672 
Tax positions related to prior years:
Gross additions120 251 382 
Settlements — (678)
Lapses on statute of limitations(3,187)(3,414)(4,401)
Balance as of December 31$15,532 $15,204 $14,886